ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 180 filers reported holding ASCENDIS PHARMA A/S in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $642,000 | -28.2% | 6,863 | -31.5% | 0.00% | – |
| Q2 2023 | $894,000 | +735.5% | 10,013 | +901.3% | 0.00% | – |
| Q1 2023 | $107,000 | -18.3% | 1,000 | -6.2% | 0.00% | – |
| Q4 2022 | $131,000 | -15.5% | 1,066 | -29.1% | 0.00% | – |
| Q3 2022 | $155,000 | -32.6% | 1,503 | -39.2% | 0.00% | – |
| Q2 2022 | $230,000 | -18.1% | 2,474 | +3.6% | 0.00% | – |
| Q1 2022 | $281,000 | +26.0% | 2,389 | +44.2% | 0.00% | – |
| Q4 2021 | $223,000 | -35.4% | 1,657 | -23.5% | 0.00% | – |
| Q3 2021 | $345,000 | +41.4% | 2,166 | +16.7% | 0.00% | – |
| Q2 2021 | $244,000 | +5.6% | 1,856 | +3.9% | 0.00% | – |
| Q1 2021 | $231,000 | -11.2% | 1,787 | +14.6% | 0.00% | – |
| Q4 2020 | $260,000 | +31.3% | 1,560 | +21.6% | 0.00% | – |
| Q3 2020 | $198,000 | +9.4% | 1,283 | +4.8% | 0.00% | – |
| Q2 2020 | $181,000 | +79.2% | 1,224 | +36.0% | 0.00% | – |
| Q1 2020 | $101,000 | -19.2% | 900 | 0.0% | 0.00% | – |
| Q4 2019 | $125,000 | +42.0% | 900 | -1.6% | 0.00% | – |
| Q3 2019 | $88,000 | -17.0% | 915 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | 0.0% | 915 | +1.7% | 0.00% | – |
| Q1 2019 | $106,000 | +68.3% | 900 | -10.0% | 0.00% | – |
| Q4 2018 | $63,000 | -11.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $71,000 | – | 1,000 | +33233.3% | 0.00% | – |
| Q2 2018 | $0 | – | 3 | -25.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 4 | -78.9% | 0.00% | – |
| Q4 2017 | $1,000 | – | 19 | +216.7% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 6 | -85.7% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 42 | -77.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |